We are proud to share that Dr. Luis Savastano, UCSF Co-Chief of NeuroEndovascular Surgery, Medical Director of Cerebrovascular Neurosurgery, will present his scientific abstract at TCT 2025, featuring research conducted with VerAvanti’s Scanning Fiber Endoscope (SFE).

Featured Presentation

About TCT 2025

The 37th Annual Transcatheter Cardiovascular Therapeutics Conference: Igniting INNOVATION, EDUCATION, and CONNECTION

Founded by Dr. Martin B. Leon, the Transcatheter Cardiovascular Therapeutics (TCT) conference is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) and the world’s foremost educational forum specializing in interventional cardiovascular medicine.

Debuting as a small gathering of 150 in 1988, TCT now attracts thousands of attendees from around the world. Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research.

The end goal: improving the survival and quality of life of patients suffering from heart and vascular disease.

At TCT 2025, the power of Acute Interventions takes center stage, highlighting the lifesaving procedures, breakthrough technologies, and cutting-edge research driving the next era of cardiovascular care. From emergency PCI and primary angioplasty to timely valvular and endovascular interventions in some of our most critically ill patients, this year’s program delivers real-world innovation and expert-driven insights, enhancing rapid-response treatments and improving patient outcomes.